ResApp Health Ltd (RAP) - Financial and Strategic SWOT Analysis Review

October 2021 | 41 pages | ID: RE73203660CEN
GlobalData

Abstracts

ResApp Health Ltd (RAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseases. The company’s products include SleepCheck, an at-home sleep apnoea screening app for customers to self-assess their risk of sleep apnoea; and ResAppDx-EU, a smartphone based acute respiratory disease diagnostic test for respiratory disease in adults and children. ResApp has license from The University of Queensland for technology that uses sound to diagnose respiratory diseases including upper respiratory tract infections, bronchitis, pneumonia, asthma and chronic obstructive pulmonary disease (COPD). Markets for ResApp’s technology include emergency department and regular clinic use by healthcare providers, at-home use by consumers and telehealth use through partnerships with telehealth service providers. ResApp is headquartered in Brisbane, Queensland, Australia.

ResApp Health Ltd Key Recent Developments

Sep 14,2021: ResApp receives advanced and overseas R&D finding
May 18,2021: Brian Leedman reappointed as Executive Director
Mar 11,2021: ResApp to progress clinical study to develop COVID-19 smartphone-based screening test
Feb 04,2021: ResApp receives $801,738 in R&D tax incentive refund and grant
Jan 11,2021: ResApp appoints VP, Commercial to progress growth strategy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

ResApp Health Ltd - Key Facts
ResApp Health Ltd - Key Employees
ResApp Health Ltd - Key Employee Biographies
ResApp Health Ltd - Major Products and Services
ResApp Health Ltd - History
ResApp Health Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
ResApp Health Ltd - Business Description
ResApp Health Ltd - SWOT Analysis
SWOT Analysis - Overview
ResApp Health Ltd - Strengths
ResApp Health Ltd - Weaknesses
ResApp Health Ltd - Opportunities
ResApp Health Ltd - Threats
ResApp Health Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ResApp Health Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 14, 2021: ResApp receives advanced and overseas R&D finding
May 18, 2021: Brian Leedman reappointed as Executive Director
Mar 11, 2021: ResApp to progress clinical study to develop COVID-19 smartphone-based screening test
Feb 04, 2021: ResApp receives $801,738 in R&D tax incentive refund and grant
Jan 11, 2021: ResApp appoints VP, Commercial to progress growth strategy
Oct 30, 2020: ResApp Health : Quarterly activities report
Jun 18, 2020: ResApp signs MOU to develop respiratory app for consumers

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

ResApp Health Ltd, Key Facts
ResApp Health Ltd, Key Employees
ResApp Health Ltd, Key Employee Biographies
ResApp Health Ltd, Major Products and Services
ResApp Health Ltd, History
ResApp Health Ltd, Subsidiaries
ResApp Health Ltd, Key Competitors
ResApp Health Ltd, Ratios based on current share price
ResApp Health Ltd, Annual Ratios
ResApp Health Ltd, Annual Ratios (Cont...1)
ResApp Health Ltd, Interim Ratios
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ResApp Health Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

ResApp Health Ltd, Performance Chart (2017 - 2021)
ResApp Health Ltd, Ratio Charts
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021